Company Number: 14999632

Analysis Date: 2025-07-29 18:47 UTC

1. Credit Opinion: DECLINE
   4D BIOMATERIALS LTD is a very recently incorporated micro-entity with minimal financial data available. Its latest accounts show nominal assets of £1 and no employees, indicating that it is either in a pre-operational or development phase. There is no evidence of trading, revenue generation, or operational cash flow. The ultimate control by 4d Medicine Ltd suggests it is a subsidiary or related entity likely dependent on external funding. Given the absence of financial substance and operating history, the company currently lacks the capacity to service debt or meet commercial credit obligations.

2. Financial Strength:
   The balance sheet reflects net assets of only £1 with current assets also at £1 and no liabilities reported. This indicates negligible tangible or intangible assets and no working capital. The micro-entity exemption and lack of audit confirm limited financial data disclosures. Such a balance sheet is typical of a start-up entity without meaningful capitalization or operational activity. There is no retained earnings or profit reserves to provide a cushion against financial stress.

3. Cash Flow Assessment:
   No cash or liquid assets are reported beyond the nominal £1 current asset figure, and there are no employees or indications of ongoing business operations generating revenue or positive cash flow. The lack of working capital means the company cannot self-fund normal operating expenses or debt servicing. Any funding or liquidity requirements would need to be met via shareholder injections or external capital.

4. Monitoring Points:

• Filing of next accounts and confirmation of commencement of trading activities.
• Generation of revenue and positive cash flow to support working capital needs.
• Capital injections or loans from parent or related parties to sustain operations.
• Any changes in director appointments or ownership structure that might impact control or financial support.
• Development milestones or contracts in the medical instruments sector that demonstrate business viability.